The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical precision. Across operating rooms, scanners, and even blood tests, ...

Diamond nanoparticles containing nitrogen-vacancy centers can now monitor cellular metabolism in real time, targeting specific organelles while tracking particle movement inside living cells.

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

Targeting and treating diseases first requires being able to find specific cells-which is challenging because they travel within the body and can "hide." Now, a new round of funding will support ...

Abstract: Digital staining is an artificial intelligence-based technology that replaces the conventional staining process. This technology addresses the challenges associated with the traditional ...

Mexican officials say they have arrested a man accused of helping plan and order the killing of a widely respected mayor in Michoacan, marking the first major break in a case that has shaken the ...

The findings of this study are valuable as it demonstrates that when treatment is initiated during acute infection, HIV specific CD8 T cell responses are maintained long term and continued ...

More for You 'Keep a big suitcase, some shooters ready': Rajasthan IAS officer seeks police protection, accuses husband of demanding divorce at gunpoint ‘7 days per week, 12 hours work’: IIT ...

Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. Watch the news briefing by ...